CEO Follicular Lymphoma Foundation (FLF). Passionate about accelerating scientific progress, so we can dramatically improve patients outcomes and lives.
📢Join our session on emerging FL treatments, covering CAR-T therapy, bispecific antibodies, and more! Hear a patient’s journey and connect with experts on the latest in FL care.
🗓️Date: Nov 25, 2024
⏰Time: 9:30 - 10:30 | 14:30 - 15:30
🔗Register now! https://t.co/kkkPWxmIyV
Listen to Dr Mitchell Smith, FLF’s Chief Medical Officer, as he highlights the importance of your voice.
📢 Your opinion matters! 📢
Help shape the future of FL care and improve treatment decisions for FL patients! Click the link in our bio to fill out our latest survey.
They partied , they bet on elections , they crashed the economy, they broke every public service, they destroyed integrity and honesty in public office , they paid their mates billions , they put their friends in the House of Lords, they gave their cronies knighthoods, they went into the jungle , they lied again and again, they were convicted by police, they went on holiday when they shouldn’t and they have the cheek to question Keir Starmer’s work ethic. I would never take anything for granted but I hope they are annihilated on Thursday. The worst people and government we have ever had!
P.S good afternoon all 😊❤️
Delighted to announce the publication of Fast Facts for Patients: Follicular Lymphoma.
Sincere thanks to #Karger and to patients from our Super Supporters Group.
Available as a free download from here: https://t.co/ghSJaiRr6M
What an incredible experience at #ASH2023! The weekend was filled with thought-provoking discussions & collaborative meetings. Bonds have been tightened and new relationships formed as we unite to accelerate finding a cure for FL. Stay tuned as we share more details in Jan!
“Don’t worry about why it can’t happen. Just make it happen” ⭐️ - Ross L. Levine, M.D., from @MSKCancerCenter & LLS Excellence in Scientific Service award winner talking about the approach of the blood cancer research community 🔬#ASH23
Yesterday's session on Lymphomagenesis uncovered insights into lymphoma biology & therapeutic strategies, as well as a session on the arrival of new technologies.
We look forward to sharing our key scientific insights from #ASH2023@bloodcancer_uk@BloodCancer_Res
Meet the faces behind our CURE FL Awards Cycle 1 👋
Collaborating with the Milken Institute, the FLF launched the CURE FL Awards in Dec 2022.
More about our CURE FL Awards: https://t.co/6G64VC8L8C
We need better biomarkers for FL, to transform patient outcomes. Partnered with the Mark Foundation for Cancer Research to tackle this need together. At #ASH2023, we co-hosted a workshop with investigators, with a goal to establish a collaborative grant programme focused on this.
Proud of @Meta's role in launching AI Alliance, a new coalition of innovators across academia, research, science and industry that seeks to advance AI that is open, innovative and responsible. Read @dariogila's piece in Fortune for more. https://t.co/BxyFt6Qfc9
Excited to share FLF's new parternship with @LLSusa The partnership, aptly named 'LLS FLF Research United to CURE FL', marks a significant milestone in accelerating leading edge research for this type of lymphoma and promises hope for patients and families affected by FL. #CureFL
@Cure_FL and @LLSusa have joined forces to tackle a shared goal – to #CureFL. This partnership marks a significant milestone in accelerating leading research and promises hope for patients and families affected by FL.
Read more 👉 https://t.co/ZTcyysgwEo
@Cure_FL and @LLSusa have joined forces to tackle a shared goal – to #CureFL. This partnership marks a significant milestone in accelerating leading research and promises hope for patients and families affected by FL.
Read more 👉 https://t.co/ZTcyysgwEo
🗣 Did you know, June is Cancer Immunotherapy Month?
View all the latest information in #myeloproliferativeneoplasms, arranged by therapeutic class and intervention on our website: https://t.co/cse0TCmzCf
#MPN#cancertreatment
After 30 June, the COVID-19 vaccine will only be offered to those at higher risk of serious infection.
People aged five or above (on 31 August 2022) can still get their first or second COVID-19 vaccines until 30 June. https://t.co/kFXGT0nmm2